|
|
|
Volumn 23, Issue 6 SUPPL. 16, 1996, Pages 51-54
|
|
Preliminary results of a phase I/II clinical trial of paclitaxel and carboplatin in non-small cell lung cancer
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
CARBOPLATIN;
PACLITAXEL;
ADULT;
AGED;
AREA UNDER THE CURVE;
BLOOD TOXICITY;
CANCER COMBINATION CHEMOTHERAPY;
CLINICAL ARTICLE;
CLINICAL TRIAL;
CONFERENCE PAPER;
DOSE RESPONSE;
FEMALE;
HUMAN;
INTRAVENOUS DRUG ADMINISTRATION;
LUNG NON SMALL CELL CANCER;
MALE;
MAXIMUM PERMISSIBLE DOSE;
NAUSEA;
PHASE 1 CLINICAL TRIAL;
PHASE 2 CLINICAL TRIAL;
PRIORITY JOURNAL;
SENSORY NEUROPATHY;
TREATMENT OUTCOME;
VOMITING;
AGED;
AGED, 80 AND OVER;
ANTINEOPLASTIC AGENTS, PHYTOGENIC;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
CARBOPLATIN;
CARCINOMA, NON-SMALL-CELL LUNG;
DRUG ADMINISTRATION SCHEDULE;
DRUG TOLERANCE;
FEMALE;
HUMANS;
INFUSIONS, PARENTERAL;
LUNG NEOPLASMS;
MALE;
MIDDLE AGED;
PACLITAXEL;
PERIPHERAL NERVOUS SYSTEM DISEASES;
|
|
EID: 0030451448
PISSN: 00937754
EISSN: None
Source Type: Journal
DOI: None Document Type: Conference Paper |
|
Times cited : (22)
|
|
References (7)
|
